United States
BioTAB Healthcare is an innovative company dedicated to enhancing the quality of life for patients. Their focus lies in the advancement of Pneumatic Compression Therapy (PCT), a crucial element in the treatment of edema-related conditions such as Lymphedema, Chronic Venous Insufficiency, and Venous Ulcers. Through recent studies, it has been demonstrated that intermittent pneumatic compression, in combination with other appropriate therapies, not only alleviates the discomfort of edema but also accelerates the healing process for venous ulcers. Moreover, the ease of use and convenience of Pneumatic Compression Pumps make them a promising solution for patients.
Founded in 2003 and headquartered in the United States, BioTAB Healthcare operates within the Health Care, Manufacturing, Medical Devices, CRM, and Sales industries. As of now, there is no available information regarding their last investment and the investors involved. However, with their strong focus on improving patient outcomes and addressing challenging medical conditions, BioTAB Healthcare presents a compelling investment opportunity. Their dedication to driving innovation in the healthcare sector and the potential to make a positive impact on the lives of countless individuals make them a noteworthy prospect for venture capital firms seeking impactful investment opportunities in the healthcare and medical technology space.
